This multicenter, randomized, double-blind trial demonstrates that Tongxinluo capsule + standard #Statin therapy increases minimum fibrous cap thickness and reduces lipid arc in #AcuteCoronarySyndrome patients.
#STTT #OpenAccess: doi.org/10.1038/s413...